153 related articles for article (PubMed ID: 33257285)
1. Outcome and Prognostic Features in Pediatric Acute Megakaryoblastic Leukemia Without Down Syndrome: A Retrospective Study in China.
Wang Y; Lu A; Jia Y; Zuo Y; Zhang L
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e301-e308. PubMed ID: 33257285
[TBL] [Abstract][Full Text] [Related]
2. [Clinical features and prognosis of pediatric acute megakaryocytic leukemia].
Luo TM; Yu J; An XZ
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Jun; 23(6):613-620. PubMed ID: 34130784
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Prognosis of 27 Patients with Childhood Acute Megakaryoblastic Leukemia.
Qi H; Mao Y; Cao Q; Sun X; Kuai W; Song J; Ma L; Hong Z; Hu J; Zhou G
Med Sci Monit; 2020 Jun; 26():e922662. PubMed ID: 32532951
[TBL] [Abstract][Full Text] [Related]
4. Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial.
Schweitzer J; Zimmermann M; Rasche M; von Neuhoff C; Creutzig U; Dworzak M; Reinhardt D; Klusmann JH
Ann Hematol; 2015 Aug; 94(8):1327-36. PubMed ID: 25913479
[TBL] [Abstract][Full Text] [Related]
5. Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trial.
Teyssier AC; Lapillonne H; Pasquet M; Ballerini P; Baruchel A; Ducassou S; Fenneteau O; Petit A; Cuccuini W; Ragu C; Preudhomme C; Mercher T; Sirvent N; Leverger G
Pediatr Hematol Oncol; 2017 Nov; 34(8):425-427. PubMed ID: 29303660
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
[TBL] [Abstract][Full Text] [Related]
7. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience.
Athale UH; Razzouk BI; Raimondi SC; Tong X; Behm FG; Head DR; Srivastava DK; Rubnitz JE; Bowman L; Pui CH; Ribeiro RC
Blood; 2001 Jun; 97(12):3727-32. PubMed ID: 11389009
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study.
Inaba H; Zhou Y; Abla O; Adachi S; Auvrignon A; Beverloo HB; de Bont E; Chang TT; Creutzig U; Dworzak M; Elitzur S; Fynn A; Forestier E; Hasle H; Liang DC; Lee V; Locatelli F; Masetti R; De Moerloose B; Reinhardt D; Rodriguez L; Van Roy N; Shen S; Taga T; Tomizawa D; Yeoh AE; Zimmermann M; Raimondi SC
Blood; 2015 Sep; 126(13):1575-84. PubMed ID: 26215111
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic significance of early assessment of minimal residual disease in acute myeloid leukemia with mutated NPM1 patients].
Zhao T; Zhu HH; Wang J; Jia JS; Yang SM; Jiang H; Lu J; Chen H; Xu LP; Zhang XH; Jiang B; Ruan GR; Wang DB; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):10-16. PubMed ID: 28219218
[No Abstract] [Full Text] [Related]
10. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
[TBL] [Abstract][Full Text] [Related]
12. Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome.
Pastore F; Gittinger H; Raab S; Tschuri S; Ksienzyk B; Konstandin NP; Schneider S; Rothenberg-Thurley M; Horny HP; Werner M; Sauerland MC; Amler S; Görlich D; Berdel WE; Wörmann B; Braess J; Hiddemann W; Tischer J; Herold T; Metzeler KH; Spiekermann K
Br J Haematol; 2023 Sep; 202(6):1165-1177. PubMed ID: 37455345
[TBL] [Abstract][Full Text] [Related]
13. Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of allogeneic stem-cell transplantation.
Chen Y; Cortes J; Estrov Z; Faderl S; Qiao W; Abruzzo L; Garcia-Manero G; Pierce S; Huang X; Kebriaei P; Kadia T; De Lima M; Kantarjian H; Ravandi F
J Clin Oncol; 2011 Jun; 29(18):2507-13. PubMed ID: 21555694
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of Clinical Characteristics and Prognosis in Children with Acute Megakaryoblastic Leukemia without Down Syndrome].
Lin SF; Guo SY; Liu S; Wang J; Huang K; Li Y; Fang JP; Zhou DH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):374-380. PubMed ID: 33812402
[TBL] [Abstract][Full Text] [Related]
15. Clinical Analysis of Pediatric Acute Megakaryocytic Leukemia With CBFA2T3-GLIS2 Fusion Gene.
Du Y; Yang L; Qi S; Chen Z; Sun M; Wu M; Wu B; Tao F; Xiong H
J Pediatr Hematol Oncol; 2024 Mar; 46(2):96-103. PubMed ID: 38315896
[TBL] [Abstract][Full Text] [Related]
16. Haematopoietic cell transplantation for children with acute megakaryoblastic leukaemia without Down syndrome.
Hama A; Taga T; Tomizawa D; Muramatsu H; Hasegawa D; Adachi S; Yoshida N; Noguchi M; Sato M; Okada K; Koh K; Mitsui T; Takahashi Y; Miyamura T; Hashii Y; Kato K; Atsuta Y; Okamoto Y
Br J Haematol; 2023 May; 201(4):747-756. PubMed ID: 36786154
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era.
Xue YJ; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1611-1620. PubMed ID: 30537550
[TBL] [Abstract][Full Text] [Related]
18. Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric
Huang J; Hu G; Suo P; Bai L; Cheng Y; Wang Y; Zhang X; Liu K; Sun Y; Xu L; Kong J; Yan C; Huang X
Front Oncol; 2023; 13():1116205. PubMed ID: 36874138
[TBL] [Abstract][Full Text] [Related]
19. History of consolidation is prognostic in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease-negative first complete remission.
Rashidi A; Linden MA; DeFor TE; Warlick E; Bejanyan N; Yohe S; Weisdorf DJ; Ustun C
Am J Hematol; 2017 Oct; 92(10):1032-1036. PubMed ID: 28646534
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Results of the Risk-Stratified Treatment of TCF3-PBX1-Positive Pediatric Acute Lymphoblastic Leukemia in China.
Wang Y; Xue YJ; Lu AD; Jia YP; Zuo YX; Zhang LP
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e137-e144. PubMed ID: 33221150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]